論文・総説 - 藍　真澄

分割表示  128 件中 61 - 80 件目  ／  全件表示 >>

  1. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans J Clin Invest. 2009; 119 (5): 1322-1334. ( PubMed, DOI )

  2. Asztalos BF, Swarbrick MM, Schaefer EJ, Dallal GE, Horvath KV, Ai M, Stanhope KL, Austrheim-Smith I, Wolfe BM, Ali M, Havel PJ. Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women J Lipid Res. 2009; ( PubMed, DOI )

  3. Ogita K, Ai M, Tanaka A, Ito Y, Hirano T, Yoshino G, Shimokado K. Serum concentration of small dense low-density lipoprotein-cholesterol during oral glucose tolerance test and oral fat tolerance test Clin Chim Acta. 2008; 387 (1-2): 36-41. ( PubMed, DOI )

  4. Lamon-Fava S, Diffenderfer MR, Barrett PH, Buchsbaum A, Nyaku M, Horvath KV, Asztalos BF, Otokozawa S, Ai M, Matthan NR, Lichtenstein AH, Dolnikowski GG, Schaefer EJ. Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins Arterioscler Thromb Vasc Biol. 2008; 28 (9): 1672-1678. ( PubMed, DOI )

  5. Ai M, Otokozawa S, Asztalos BF, Nakajima K, Stein E, Jones PH, Schaefer EJ. Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels Am J Cardiol. 2008; 101 (3): 315-318. ( PubMed, DOI )

  6. Chiba T, Shinozaki S, Nakazawa T, Kawakami A, Ai M, Kaneko E, Kitagawa M, Kondo K, Chait A, Shimokado K. Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice Atherosclerosis. 2008; 196 (1): 68-75. ( PubMed, DOI )

  7. Ai M, Tanaka A, Shoji K, Ogita K, Hase T, Tokimitsu I, Shimokado K. Suppressive effects of diacylglycerol oil on postprandial hyperlipidemia in insulin resistance and glucose intolerance Atherosclerosis. 2007; 195 (2): 398-403. ( PubMed, DOI )

  8. Shinozaki S, Chiba T, Kokame K, Miyata T, Ai M, Kawakami A, Kaneko E, Yoshida M, Shimokado K. Site-specific effect of estradiol on gene expression in the adipose tissue of ob/ob mice Horm Metab Res. 2007; 39 (3): 192-196. ( PubMed, DOI )

  9. Ogita K, Ai M, Tanaka A, Ito Y, Hirano T, Yoshino G, Shimokado K. Circadian rhythm of serum concentration of small dense low-density lipoprotein cholesterol Clin Chim Acta. 2007; 376 (1-2): 96-100. ( PubMed, DOI )

  10. Asano T, Kaneko E, Shinozaki S, Imai Y, Shibayama M, Chiba T, Ai M, Kawakami A, Asaoka H, Nakayama T, Mano Y, Shimokado K. Hyperbaric oxygen induces basic fibroblast growth factor and hepatocyte growth factor expression, and enhances blood perfusion and muscle regeneration in mouse ischemic hind limbs Circ J. 2007; 71 (3): 405-411. ( PubMed )

  11. Abe Y, Ai M, Kaneko M, Sawara M, Nagano K, Shimokado K. [Studies on factors related to delayed discharge of elderly patients from university hospitals] Nippon Ronen Igakkai Zasshi. 2007; 44 (5): 641-647. ( PubMed )

  12. Imai Y, Kaneko E, Asano T, Kumagai M, Ai M, Kawakami A, Kataoka K, Shimokado K. A novel contrast medium detects increased permeability of rat injured carotid arteries in magnetic resonance T2 mapping imaging J Atheroscler Thromb. 2007; 14 (2): 65-71. ( PubMed )

  13. Ai M, Tanaka A, Ogita K, Shimokado K. Favorable effects of early insulin secretion by nateglinide on postprandial hyperlipidemia in patients with type 2 diabetes Diabetes Care. 2006; 29 (5): 1180. ( PubMed, DOI )

  14. Ai M, Tanaka A, Baba T, Yui K, Numano F. Increased cholesteryl ester transfer protein and changes in lipid metabolism from initiating insulin therapy Ann N Y Acad Sci. 2001; 947 356-361. ( PubMed )

  15. Tanaka A, AI M, Kobayashi Y, Tamura M, Shimokado K, Numano F. Metabolism of triglyceride-rich lipoproteins and their role in atherosclerosis Ann N Y Acad Sci. 2001; 947 207-12; discussion 212-3. ( PubMed )

  16. Ai M, Tanaka A. [Guidelines for plasma lipid and lipoprotein concentration] Nippon Rinsho. 2001; 59 Suppl 2 759-762. ( PubMed )

  17. Ai M, Tanaka A, Ogita K, Sekinc M, Numano F, Numano F, Reaven GM. Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes J Am Coll Cardiol. 2001; 38 (6): 1628-1632. ( PubMed )

  18. Ai M, Tanaka A, Tomie N, Ogita K, Sekine M, Numano F, Numano F. Triglyceride-rich lipoprotein cholesterol exceeds low-density lipoprotein cholesterol in hypertriglyceridemia patients Horm Metab Res. 2001; 33 (10): 612-617. ( PubMed, DOI )

  19. Tanaka A, Ai M. [Hyper-remnant-like particles (RLP) lipoproteinemia] Nippon Rinsho. 2001; 59 Suppl 3 107-111. ( PubMed )

  20. Tanaka A, Ai M. [Hyperlipidemia, definition, cause, frequency] Nippon Rinsho. 2001; 59 Suppl 2 653-660. ( PubMed )

< 前のページ - 次のページ >

このページの先頭へ▲